NAUTILUS BIOTECHNOLOGY INC's ticker is and the CUSIP is 63909J958. A total of 2 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2 | -99.7% | 700 | -99.7% | 0.00% | -100.0% |
| Q1 2023 | $668 | – | 241,400 | +241300.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 100 | -90.0% | 0.00% | – |
| Q2 2022 | $2,000 | -87.5% | 1,000 | -73.0% | 0.00% | – |
| Q1 2022 | $16,000 | -65.2% | 3,700 | -58.4% | 0.00% | – |
| Q4 2021 | $46,000 | +4500.0% | 8,900 | +8800.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |